×
Spectral Diagnostics EBIT 2010-2025 | EDTXF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Spectral Diagnostics ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Spectral Diagnostics EBIT 2010-2025 | EDTXF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Spectral Diagnostics ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$182.7B
Intuitive Surgical (ISRG)
$168.4B
IDEXX Laboratories (IDXX)
$50.6B
Edwards Lifesciences (EW)
$47.6B
Alcon (ALC)
$39.1B
DexCom (DXCM)
$31.6B
IQVIA Holdings (IQV)
$31.5B
Mettler-Toledo (MTD)
$26.3B
STERIS (STE)
$24.4B
Waters (WAT)
$17.3B
SONOVA HOLDING (SONVY)
$17B
Hologic (HOLX)
$14.9B
Penumbra (PEN)
$9.8B
Sysmex ADR (SSMXY)
$8.3B
Globus Medical (GMED)
$8.2B
Masimo (MASI)
$7.8B
Teleflex (TFX)
$5.5B
Glaukos (GKOS)
$5.1B
TransMedics (TMDX)
$4.1B
Integer Holdings (ITGR)
$3.7B
LivaNova (LIVN)
$2.9B
Alphatec Holdings (ATEC)
$2.4B
Veracyte (VCYT)
$2.3B
PROCEPT BioRobotics (PRCT)
$2.2B
Artivion (AORT)
$2B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.9B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Pulse Biosciences (PLSE)
$1.1B